GUJARAT THEMIS BIOSYN LIMITED : INTER-SE TRANSFER OF EQUITY SHARES WORTH UP TO RS 20 CR

• Sachin D. Patel, promoter, to acquire up to 5,25,000 equity shares from Pharmaceutical Business Group (India) Limited. • Proposed acquisition date is July 8-14, 2026, at ₹395.75 per share. • The shares represent up to 0.50% of the company's share capital. • The transfer is inter-se among promoter and promoter group members. • The acquirer declares compliance with SEBI (SAST) Regulations, 2011, exemption under regulation 10(1)(a)(ii). • Shareholding of Dr. Sachin Patel (acquirer) will increase from 2.29% to 2.77% post-transaction. Impact: Neutral (Internal share transfer within promoter group, no change in control or external acquisition.)

Gujarat Themis Biosyn Limited

Open attachment

← Back to feed